Q517--Contingency Hazardous Compounding Services VHA VISN 10 VA Medical Facilities

Award Notice

• Award Number: 36C25026D0048

• Award Date: 04-02-2026

• Awardee: OPTUM INFUSION SERVICES 308, LLC

• Award Amount: $7,570,831.40

• Contractor's UEI: RN5UVE9XMJN4

• Awardee Address: 485 N JUNIPER DR STE 2, CHANDLER, AZ 85226

• Solicitation Number: 36C25026Q0292

• Product Service Code (PSC): Q517

• NAICS Code: 621999

• Line Item Number: 650

Contingency Hazardous Compounding Services for VHA VISN 10 VA Medical Facilities.

• Address: Department of Veterans Affairs, Network Contracting Office - NCO 10, 3140 Governor’s Place Blvd. Suite 210, Kettering OH 45409-1337

• Point of Contact: Josh Kovar (Joshua.Kovar@VA.gov)

• This document serves as an award notice. All questions regarding this award should be directed to the Contracting Officer via email.

Solicitation / RFP / RFQ

This is a combined synopsis/solicitation notice for commercial items, issued as a Request for Quotation (RFQ) under Federal Acquisition Regulation (FAR) subpart 12.6. The Department of Veterans Affairs (VA) VISN 10 is seeking Hazardous Compounding Services for its medical facilities in Indiana, Ohio, and Michigan. This is a requirements contract with no minimum guaranteed amount, intended to be used as a contingency when facilities cannot compound these agents themselves.

• Compounding Services: Aseptic compounding of hazardous chemotherapy agents and intravenous (IV) tubing based on patient-specific prescriptions.

• Facility Compliance: Services must be performed at an FDA 503A compliant facility meeting all federal, state, and local laws, including USP 797 and USP 800 standards.

• Drug Supply: Contractor supplies all drugs; pricing is based on Average Wholesale Price (AWP) ± 0.00%, with potential adjustments at task order placement. The billed amount for drugs shall not exceed AWP plus 5% at the time of service.

• Delivery: Orders submitted by 3:00 PM EST the day prior to infusion, with delivery by 9:00 AM EST the following day. Shipping costs are included.

• Quality Control: Contractor must maintain certifications, provide quality control program, and adhere to performance standards outlined in the Quality Assurance/Performance Requirements table.

• Contract Type: Requirements IDIQ contract.

• Period of Performance: Base Year (5/1/2026 – 4/30/27) with four option years.

• Maximum Contract Value: $8,500,000.00 (Contract Ceiling).

• Submission Deadline: March 20, 2026, 13:30 Eastern Time.

• Submission Format: Quotes must be submitted electronically, with specific file formats (PDF for administrative/technical/past performance, Excel for pricing). Files must be named according to a specified format.

• Evaluation Criteria: Award will be based on a comparative evaluation of quotes, considering Administrative, Price, Technical, Past Performance, and Veterans Involvement factors. The most advantageous quote to the Government will be selected, not necessarily the lowest priced.

• Questions Deadline: March 13, 2026, 13:30 EST.

• Competition Type: Full and Open Competition.

• NAICS Code: 621999 (All Other Miscellaneous Ambulatory Health Care Services) with a small business size standard of $20.5 Million.

• Set-Aside: None.

• Attachments: Several documents are attached, including Guidance Documents for Outsourcing of Compounded Sterile Products, Price-Cost Schedule, Vendor Cover Page Template, Solicitation Concurrence Table, and 26Q0292 - PPQ - Vendor Name.

• Email Size Limit: VA has a maximum allowable incoming email size limitation of 30 megabytes. Offerors exceeding this limit must split their response into multiple emails.

Form / Attachment / Pricing Sheet

This document is a Past Performance Questionnaire (PPQ) used by the Department of Veterans Affairs (VA) to gather information on a contractor's performance for a specific project. It is intended to help the government assess past performance risk for a solicitation (RFQ# 36C25026Q0292, VHA V10 HAZ Compounding).

• Contractor/Offeror Information: Details about the offering entity, including name, address, DUNS number, and contact information.
• General Work Information: How the work was performed (e.g., Offering Entity, Predecessor Companies, Key Personnel) and the percentage of work performed by each.
• Contract Information: Specifics of the contract being referenced, including contract number, type, title, location, award date, completion date, and original/final prices.
• Project Description: Type of work performed (Federal, VA, Medical, Office, Other) and whether key personnel were assigned to the solicitation project.
• Detailed Description of Work Performed: A section for a narrative description of the project.
• Explanation of Relevancy: A section to explain how the past performance relates to the current solicitation requirements.
• Rating Sections: Detailed evaluation criteria across Quality, Schedule/Timeliness, Customer Satisfaction, Management/Personnel/Labor, Cost/Financial Management, Safety/Security, and General performance. Ratings range from Exceptional (E) to Unsatisfactory (U), with a Not Applicable (N) option.
• Summary: A final question on whether the government would hire or work with the firm again, with a comments section for detailed remarks, strengths, weaknesses, or deficiencies.

This document is crucial for any bidder responding to the referenced RFQ. It outlines the specific information the VA will use to evaluate past performance. Bidders should understand what information is requested from their references to ensure they provide comprehensive and favorable feedback. The detailed rating criteria also highlight the government's priorities and expectations for successful contract performance.

Form / Attachment / Pricing Sheet

This document is a Vendor Acknowledgment and Concurrence Table. It requires vendors to formally acknowledge receipt and concurrence with the solicitation terms, conditions, and any amendments. It also serves to collect essential company information for the bid.

• Acknowledgment of Documents: Vendors must indicate concurrence (Yes/No) for the Original Solicitation and any Amendments.
• Signature and Date: An authorized signature and date are required to confirm acknowledgment.
• Company Information: Fields are provided for Solicitation Number, Company Name, SAM UEI, Point of Contact, Signature, and Date.

Completion and submission of this table are critical for proposal acceptance. Vendors must confirm their understanding and agreement with all solicitation terms and conditions. Failure to acknowledge all amendments or indicate concurrence may lead to proposal rejection. Any exceptions or deviations must be clearly stated in the quote.

Form / Attachment / Pricing Sheet

This document is a template for a Vendor Cover Page, intended to be completed by prime contractors responding to Solicitation Number 36C25026Q0292. It serves to collect essential company and contact information required for the bid.

• Company Information: Requires the Prime Contractor's Name, DBA (if applicable), SAM UEI, Cage Code, and full address.
• Primary POC Information: Requires the name, phone number, and email address of the main point of contact.
• Company SBA Certifications: A table to mark applicable Small Business Administration certifications (SDVOSB, VOSB, EDWOSB, WOSB, 8(a), HUBZone, SDB) with expiration dates.
• Business Type: A section to indicate if the firm considers itself a Small Business Firm or an Other Than Small Business (Large Business) if no SBA certifications apply.

This template is crucial for bidders to ensure they provide all necessary identifying and certification information as part of their proposal submission for Solicitation Number 36C25026Q0292. Accurate completion is required for proposal evaluation and compliance.

Form / Attachment / Pricing Sheet

This document is a pricing sheet that outlines the costs for medications, applicable fees, and supplies for a contract period spanning a base year and four option years. Bidders are instructed to complete all tabs, including base and option years, and enter discounts or pricing in the designated yellow-highlighted cells.

• Medication Pricing: Details specific drugs, their brand/trade names, NDC numbers, estimated quantities, Average Wholesale Price (AWP) base price, and a column for the bidder to input their surcharge or discount percentage. The total pricing for each medication is calculated based on AWP, the entered discount/surcharge, and estimated contingency usage.
• Applicable Fees: Includes per diem charges (including shipping), USP 797/800 fees, delivery fees, and various mixing fees (Chemoembolic, Intrathecal, STAT). Estimated quantities and prices are provided.
• Supplies: An estimated cost of $70.00 per order for supplies is provided, with a note that vendors should charge for actual fees, not exceeding $70.00 without COR approval. A discount off the list price for supplies is also indicated.
• Option Years: Separate sheets detail pricing for Option Years 1 through 4, with identical structures to the Base Year.
• Total Sheet: Provides a summary of total estimated prices for medications, fees, and supplies across all years.

This document is critical for bidders to understand the pricing structure and to prepare their proposals. It specifies where and how to enter pricing information, including discounts or surcharges. Failure to complete all required areas may result in the proposal being considered incomplete and dismissed. The document also clarifies how the final invoiced price will be calculated, based on AWP, entered discounts/surcharges, and approved fees/supplies.

Form / Attachment / Pricing Sheet

This document is a checklist intended to guide the Veterans Affairs Medical Center (VAMC) in evaluating potential 503A compounding pharmacies for outsourcing sterile products. It serves as a template for assessing a pharmacy's compliance with regulatory, procedural, cleaning, personnel training, and quality assurance requirements.

• Pharmacy Information: Collects basic details about the pharmacy, including name, license number, contact information, and address.
• Regulatory Requirements: Assesses compliance with pharmacy licensing, USP <797> and <795> standards, HIPAA, EPA regulations, FDA/DEA registration for APIs and controlled substances, and Joint Commission standards (if applicable).
• Procedural Compliance: Evaluates policies and procedures for ingredient sourcing, documentation, adverse event reporting, aseptic technique, beyond-use dating (BUDs), and handling of specific substances like Beta-Lactams.
• Cleaning Practices: Details requirements for cleaning and disinfecting compounding areas, equipment (LAFWs, BSCs, CAIs, CACIs), and surfaces.
• Personnel Training and Competency: Outlines requirements for staff training, media-fill testing, hand hygiene, garbing, and competency evaluations.
• Finished Preparation Release Checks: Specifies visual inspection and double-check systems for compounded sterile preparations (CSPs).
• Quality Assurance Program: Assesses the existence and effectiveness of a formal QA program, including data provision, recall notification, and a designated Point of Contact (POC).

Bidders seeking to provide outsourced compounded sterile products to the VAMC should use this checklist to understand the specific standards and requirements they must meet. It outlines the critical areas the VAMC will evaluate to ensure the safety, quality, and compliance of outsourced pharmaceutical preparations. Vendors should ensure their operations align with these detailed criteria to be considered a viable partner.